1. Small molecule inhibitors of mammalian glycosylation
   Karim Almahayni et al, 2022, Matrix Biology Plus CrossRef
2. Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation
   Shin-Yun Liu et al, 2016, Oncotarget CrossRef
3. Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling
   Miao-Juei Huang et al, 2015, Oncotarget CrossRef
4. Glycosyltransferases and Gastric Cancer
   Celso A. Reis et al, 2016, Glycosignals in Cancer: Mechanisms of Malignant Phenotypes CrossRef
5. Diagnostic utility of glycosyltransferase mRNA expression in gastric cancer
   Showkat Ahmad Bhat et al, 2018, Hematology/Oncology and Stem Cell Therapy CrossRef
6. Establishment of a highly metastatic model with a newly isolated lung adenocarcinoma cell line
   YONG-QI CUI et al, 2015, International Journal of Oncology CrossRef
7. Down regulation of GALNT3 contributes to endothelial cell injury via activation of p38 MAPK signaling pathway
   Liwei Guo et al, 2016, Atherosclerosis CrossRef
8. Tumor‐associated antigens: Tn antigen, sTn antigen, and T antigen
   C. Fu et al, 2016, HLA CrossRef
9. Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives
   Joanne Chia et al, 2016, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
10. Glycomic Approaches for the Discovery of Targets in Gastrointestinal Cancer
    Stefan Mereiter et al, 2016, Frontiers in Oncology CrossRef
11. Interactome analysis of transforming growth factor-β-activated kinase 1 inHelicobacter pylori-infected cells revealed novel regulators tripartite motif 28 and CDC37
    Olga Sokolova et al, 2018, Oncotarget CrossRef
12. Mutual regulation between glycosylation and transforming growth factor-β isoforms signaling pathway
    Zhuo Chen et al, 2023, International Journal of Biological Macromolecules CrossRef
13. Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric Cancer
    Huimei Xu et al, 2023, BMC Medical Genomics CrossRef
14. Analysis to Estimate Genetic Variations in the Idarubicin-Resistant Derivative MOLT-3
    Tomoyoshi Komiyama et al, 2016, International Journal of Molecular Sciences CrossRef
15. Protein glycosylation in cancer
    Wagner B. Dias et al, 2024, Translational Glycobiology in Human Health and Disease CrossRef
16. MiR‐206 inhibits proliferation and migration of prostate cancer cells by targeting CXCL11
    Yao Wang et al, 2018, The Prostate CrossRef
17. C1GALT1 in health and disease (Review)
    Xiaojie Sun et al, 2021, Oncology Letters CrossRef
18. CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer
    Liang Wang et al, 2016, Molecular Medicine Reports CrossRef
19. Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation
    Zhi-Qiang Wang et al, 2014, Oncotarget CrossRef
20. Anti-Cancer Potential of Afzelin towards AGS Gastric Cancer Cells
    Iwona Radziejewska et al, 2021, Pharmaceuticals CrossRef
21. Mucin-Type O-Glycosylation in Gastric Carcinogenesis
    Henrique Duarte et al, 2016, Biomolecules CrossRef
22. RNA interference-mediated silencing of ppGalNAc-T1 and ppGalNAc-T2 inhibits invasion and increases chemosensitivity potentially by reducing terminal α2,3 sialylation and MMP14 expression in triple-negative breast cancer cells
    Hao Qiu et al, 2017, Molecular Medicine Reports CrossRef
23. Barbaloin loaded polydopamine-polylactide-TPGS (PLA-TPGS) nanoparticles against gastric cancer as a targeted drug delivery system: Studies in vitro and in vivo
    Yi-Ran Wang et al, 2018, Biochemical and Biophysical Research Communications CrossRef
24. The polypeptide N‐acetylgalactosaminyltransferase 4 exhibits stage‐dependent expression in colorectal cancer and affects tumorigenesis, invasion and differentiation
    Xialin Yan et al, 2018, The FEBS Journal CrossRef
25. Anti-cancer effect of combined action of anti-MUC1 and rosmarinic acid in AGS gastric cancer cells
    Iwona Radziejewska et al, 2021, European Journal of Pharmacology CrossRef